Literature DB >> 25867140

Functional reconstitution and channel activity measurements of purified wildtype and mutant CFTR protein.

Paul D W Eckford1, Canhui Li1, Christine E Bear2.   

Abstract

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) is a unique channel-forming member of the ATP Binding Cassette (ABC) superfamily of transporters. The phosphorylation and nucleotide dependent chloride channel activity of CFTR has been frequently studied in whole cell systems and as single channels in excised membrane patches. Many Cystic Fibrosis-causing mutations have been shown to alter this activity. While a small number of purification protocols have been published, a fast reconstitution method that retains channel activity and a suitable method for studying population channel activity in a purified system have been lacking. Here rapid methods are described for purification and functional reconstitution of the full-length CFTR protein into proteoliposomes of defined lipid composition that retains activity as a regulated halide channel. This reconstitution method together with a novel flux-based assay of channel activity is a suitable system for studying the population channel properties of wild type CFTR and the disease-causing mutants F508del- and G551D-CFTR. Specifically, the method has utility in studying the direct effects of phosphorylation, nucleotides and small molecules such as potentiators and inhibitors on CFTR channel activity. The methods are also amenable to the study of other membrane channels/transporters for anionic substrates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867140      PMCID: PMC4401239          DOI: 10.3791/52427

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  34 in total

1.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

3.  A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  M Ramjeesingh; C Li; E Garami; L J Huan; M Hewryk; Y Wang; K Galley; C E Bear
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

4.  Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

Authors:  Juan L Mendoza; André Schmidt; Qin Li; Emmanuel Nuvaga; Tyler Barrett; Robert J Bridges; Andrew P Feranchak; Chad A Brautigam; Philip J Thomas
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Mark F Rosenberg; Alhaji Bukar Kamis; Luba A Aleksandrov; Robert C Ford; John R Riordan
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

6.  Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner.

Authors:  Paul D W Eckford; Canhui Li; Mohabir Ramjeesingh; Christine E Bear
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

7.  A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability.

Authors:  Leigh Wellhauser; Patrick Kim Chiaw; Stan Pasyk; Canhui Li; Mohabir Ramjeesingh; Christine E Bear
Journal:  Mol Pharmacol       Date:  2009-04-01       Impact factor: 4.436

8.  Synthesis and properties of molecular probes for the rescue site on mutant cystic fibrosis transmembrane conductance regulator.

Authors:  Bashar Alkhouri; Robert A Denning; Patrick Kim Chiaw; Paul D W Eckford; Wilson Yu; Canhui Li; Jovanka J Bogojeski; Christine E Bear; Russell D Viirre
Journal:  J Med Chem       Date:  2011-11-21       Impact factor: 7.446

9.  Functional reconstitution of purified human Hv1 H+ channels.

Authors:  Seok-Yong Lee; James A Letts; Roderick MacKinnon
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

10.  Proton-dependent gating and proton uptake by Wzx support O-antigen-subunit antiport across the bacterial inner membrane.

Authors:  Salim T Islam; Paul D W Eckford; Michelle L Jones; Timothy Nugent; Christine E Bear; Christian Vogel; Joseph S Lam
Journal:  mBio       Date:  2013-09-10       Impact factor: 7.867

View more
  2 in total

1.  Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface.

Authors:  Stephanie Chin; Donghe Yang; Andrew J Miles; Paul D W Eckford; Steven Molinski; B A Wallace; Christine E Bear
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

2.  Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

Authors:  Stephanie Chin; Mohabir Ramjeesingh; Maurita Hung; June Ereño-Oreba; Hong Cui; Onofrio Laselva; Jean-Philippe Julien; Christine E Bear
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.